Is “pre-sepsis” the new sepsis? A narrative review
PLOS Pathogens · 31.07.2025 · 21 (7) · e1013372
DOI: 10.1371/journal.ppat.1013372 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift PLOS Pathogens, online erschienen am 31.07.2025. Verfasst von Rémy Gerard und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Neonatal Intensive Care Unit, Bordeaux University Hospital, Bordeaux, France. Hauptthemen laut MEDLINE: Sepsis, Host-Pathogen Interactions, Multiple Organ Failure. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 89 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Sepsis
Abstract (Originalsprache)
Sepsis is a life-threatening condition caused by a dysregulated immune response to infection, leading to organ dysfunction and high mortality. Despite advances in treatment, sepsis remains difficult to manage. Historically, the concept of sepsis evolved from ancient observations of infection-related decay to the germ theory of the 19th century. The latest Sepsis-3 definition describes sepsis as life-threatening organ dysfunction due to a dysregulated host response. However, this clinical characterization may be too late for effective intervention. The concept of endotypes and the ontological data applied to sepsis highlight the substantial heterogeneity in pathophysiological pathways leading to this endpoint. We propose a focus on the “pre-sepsis” phase, where early immune dysregulation arises before significant organ damage. This phase represents the host’s initial response to infection, preceding sepsis and, thus, organ failure. Currently, there is no formal definition of “pre-sepsis”, but this phase could be defined on the basis of early biological pathways in host-pathogen interactions, such as those involving endogenous carbon monoxide. By focusing on “pre-sepsis” and developing tools to detect it, clinicians could intervene earlier and potentially prevent the progression to sepsis. This approach may lead to improved outcomes and more personalized treatments, targeting specific immune pathways tailored to patient profiles. Ultimately, this shift could address existing challenges in sepsis treatment, offering new directions for clinical research and therapeutic development.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Pediatrics, Neonatal Intensive Care Unit, Bordeaux University Hospital, Bordeaux, France.
- Univ. Bordeaux, ImmunoConcEpT, CNRS UMR 5164, Inserm ERL 1303, Bordeaux, France.
- Department of Anaesthesia and Intensive Care, Bordeaux University Hospital, Pessac, France.
- Univ. Bordeaux, Immuno ConcEpT, CNRS UMR 5164, Bordeaux, France.
- Presidential Fellow, Chapman University, Orange, California, United States of America.
- Department of Immunology and Immunogenetics, Bordeaux University Hospital, Bordeaux, France.
ORCID-Profile: Rémy Gerard
Zitieren
APA
Gerard, R., Dewitte, A., Gross, F., Pradeu, T., Lemoine, M., Goret, J., & Mamani-Matsuda, M. (2025). Is “pre-sepsis” the new sepsis? A narrative review. PLOS Pathogens, 21(7), e1013372. https://doi.org/10.1371/journal.ppat.1013372
Vancouver
Gerard R, Dewitte A, Gross F, Pradeu T, Lemoine M, Goret J, et al. Is “pre-sepsis” the new sepsis? A narrative review. PLOS Pathogens. 2025;21(7):e1013372. doi:10.1371/journal.ppat.1013372
BibTeX
@article{Gerard2025,
author = {Gerard, Rémy and Dewitte, Antoine and Gross, Fridolin and Pradeu, Thomas and Lemoine, Maël and Goret, Julien and Mamani-Matsuda, Maria},
title = {Is “pre-sepsis” the new sepsis? A narrative review},
journal = {PLOS Pathogens},
year = {2025},
volume = {21},
number = {7},
pages = {e1013372},
doi = {10.1371/journal.ppat.1013372}
}
EUVIMED